3//SEC Filing
GAP COINVESTMENTS III, LLC 3
Accession 0000950142-22-000204
CIK 0001868734other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:04 PM ET
Size
15.2 KB
Accession
0000950142-22-000204
Insider Transaction Report
Form 3
GAP Coinvestments CDA, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common stock, par value $0.00001 ("Common Stock") (2,426,470 underlying)
General Atlantic (CIN), L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common stock, par value $0.00001 ("Common Stock") (2,426,470 underlying)
GAP COINVESTMENTS III LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common stock, par value $0.00001 ("Common Stock") (2,426,470 underlying)
GAP COINVESTMENTS IV LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common stock, par value $0.00001 ("Common Stock") (2,426,470 underlying)
GAP Coinvestments V, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common stock, par value $0.00001 ("Common Stock") (2,426,470 underlying)
Footnotes (4)
- [F1]Each share of Series B Preferred Stock will automatically convert into shares of Common Stock of CinCor Pharma, Inc. (" the Issuer"), on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
- [F2]Reflects securities held directly by General Atlantic (CIN), L.P. ("GA CIN"), a Delaware limited partnership. The limited partners of GA CIN are the following investment funds (the "GA Funds"): General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), General Atlantic Partners (Bermuda) EU, L.P., a Bermuda limited partnership ("GAP Bermuda EU"), General Atlantic Partners (Lux) SCSp, a Luxembourg special limited partnership ("GAP Lux"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V").
- [F3]The general partner of GA (CIN) is General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"). The general partner of GAP Lux is General Atlantic GenPar, (Lux) SCSp, a Luxembourg special limited partnership ("GA GenPar Lux") and the general partner of GA GenPar Lux is General Atlantic (Lux) S.a.r.l., a Luxembourg company ("GA Lux"). The general partner of GAP Bermuda EU and the sole shareholder of GA Lux is General Atlantic GenPar (Bermuda), L.P., a Bermuda limited partnership ("GenPar Bermuda"). GAP (Bermuda) L.P. ("GAP (Bermuda) LP") is the general partner of GenPar Bermuda.
- [F4]The general partner of GAP 100 is General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"). General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). The members of the GA Management Committee are also the members of the management committee of GAP (Bermuda) LP. Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001282203
Filing Metadata
- Form type
- 3
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:04 PM ET
- Size
- 15.2 KB